["{\n\"step_by_step_thinking\": \"The question is asking about antimalarial drugs used for causal prophylaxis. Based on the provided documents, it seems that the relevant article 'Rodent systems (Plasmodium berghei-Anopheles Stephensi) for screening compounds for potential causal prophylaxis' mentions an in vivo screening system where drugs are administered to rats or mice and challenged with sporozoites. This suggests that the antimalarial drug is acting at the stage of pre-erythrocytic schizogony, as it is being used to prevent infection by blocking the development of parasites from sporozoite invasion to liver-stage development.\",\n\"answer_choice\": \"C\"\n}"]